| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Nuclear Medicine and Second Department of Surgery, Kyoto University Faculty of Medicine, Kyoto
Department of Radiology, Fukui Medical School, Fukui, Japan
Correspondence: For correspondence or reprints contact: Tatsuo Torizuka, MD, Department of Nuclear Medicine, Kyoto University Faculty of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606 Japan.
ABSTRACT
Methods: Thirty-two tumors in 30 patients with hepatocellular carcinoma (HCC) were studied preoperatively using PET with 18F-labeled 2-fluoro-2-deoxy-D-glucose (FDG) to evaluate the metabolic activity of the lesions after interventional therapy. All patients had received transcatheter arterial chemoembolization therapy using iodized oil (Lipiodol, Laboratoire Guerbet, Alnaysous-Bois, France) before the PET study. The tumors were 2 to 18 cm in diameter. FDG uptake at 48 to 60 min after tracer injection was used to determine the standardized uptake value (SUV). The SUVs of the tumor and nontumor regions of the liver were calculated to obtain the tumor-to-nontumor ratio (SUV ratio). The PET results were compared with the findings of CT and histologic examination. Results: The tumors were divided into three types, consisting of those with increased FDG uptake (SUV ratio of 1.07–2.66, Type A, n = 19), similar FDG uptake to the surrounding nontumor region (SUV ratio of 0.77–1.04, Type B, n = 7) and decreased or absent FDG uptake (SUV ratio of 0.13–0.58, Type C, n = 6). In histologic examination, viable HCC tissue remained in all Type A and B tumors, whereas more than 90% necrosis was found in the Type C tumors, indicating that interventional therapy had been effective. These PET findings reflected tumor viability more accurately than the extent of intratumor Lipiodol retention on CT images. Conclusion: FDG-PET appears to be a valuable method for the assessment of tumor viability after interventional therapy for HCC.
Key Words: hepatocellular carcinoma • FDG-PET • interventional therapy
This article has been cited by other articles:
|
|
 |
|
  A. L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, A. C. Larson, and F. H. Miller Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres Am. J. Roentgenol., March 1, 2007; 188(3): 768 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. von Schulthess, H. C. Steinert, and T. F. Hany Integrated PET/CT: Current Applications and Future Directions Radiology, February 1, 2006; 238(2): 405 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J Beadsmoore, H K Cheow, E Sala, D J Lomas, P Gibbs, V Save, M E D Alison, and K K Balan Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging Br. J. Radiol., September 1, 2005; 78(933): 841 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B B Chin and R L Wahl 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies Gut, June 1, 2003; 52(90004): iv23 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Ho, S. C.H. Yu, and D. W.C. Yeung 11C-Acetate PET Imaging in Hepatocellular Carcinoma and Other Liver Masses J. Nucl. Med., February 1, 2003; 44(2): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Delbeke and C. W. Pinson 11C-Acetate: A New Tracer for the Evaluation of Hepatocellular Carcinoma J. Nucl. Med., February 1, 2003; 44(2): 222 - 223. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
